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Dendritic cells (DCs) are the main inducers and regulators of cytotoxicT lymphocyte (CTL)
responses against viruses and tumors. One checkpoint to avoid misguided CTL activation,
which might damage healthy cells of the body, is the necessity for multiple activation
signals, involving both antigenic as well as additional signals that reﬂect the presence
of pathogens. DCs provide both signals when activated by ligands of pattern recognition
receptors and “licensed” by helper lymphocytes. Recently, it has been established that
such T cell licensing can be facilitated by CD4+ T helper cells (“classical licensing”) or
by natural killer T cells (“alternative licensing”). Licensing regulates the DC/CTL cross-talk
at multiple layers. Direct recruitment of CTLs through chemokines released by licensed
DCs has recently emerged as a common theme and has a crucial impact on the efﬁ-
ciency of CTL responses. Here, we discuss recent advances in our understanding of DC
licensing for cross-priming and implications for the temporal and spatial regulation under-
lying this process. Future vaccination strategies will beneﬁt from a deeper insight into the
mechanisms that govern CTL activation.
Keywords: chemokines, dendritic cells,T cell activation, NKT cells, costimulation, antigen presentation
INTRODUCTION
Dendritic cells (DCs) are responsible for activating T cells. CD8+
T cells, also referred to as cytotoxic T lymphocytes (CTLs), are
pivotal for host defense against infection with viruses, intracellu-
lar bacteria, and parasites, and for immune surveillance of tumor
cells, by scanning the surfaces of body cells for alterations. They
detect and destroy infected or transformed cells after T cell recep-
tor (TCR)-mediated recognition of, e.g., endogenous viral peptide
antigens, which are presented on major histocompatibility com-
plex (MHC) class I molecules on the cell surface. However, the
risk of misguided destruction of healthy cells by autoreactive
CTLs is diminished by the need for additional activation signals
that are upregulated under inﬂammatory conditions. These sig-
nals can only be provided by professional antigen-presenting cells
(APCs). However, if an intracellular pathogen does not infect
APCs, or if a tumor is not derived from an APC, there must
be mechanisms that allow for presentation of exogenous anti-
gen to naïve CTLs. Indeed, APCs possess the ability to acquire
and process antigens derived from virus-infected or tumor cells
in a process called cross-priming. The cell type best character-
ized to be capable of this task are murine CD8+ DCs (Shortman
and Heath, 2010), but also B cells (Hon et al., 2005), certain
macrophages (Ramirez and Sigal, 2002),neutrophilic granulocytes
(Tvinnereim et al., 2004), mast cells, and liver sinusoidal endothe-
lial cells (Limmer et al., 2000) have been reported to be capable of
cross-presentation.
Since its ﬁrst description in 1976 (Bevan, 1976), cross-priming
has been found to be implicated in a broad variety of physiolog-
ical and pathophysiological processes, ranging from host defense
against viruses and vaccinations to CTL-mediated autoimmune
disease (Kurts et al., 2010). Under normal conditions, cross-
presentation of self-antigens leads to deletion of autoreactive CTLs
rather than to an autoimmune response, a phenomenon termed
cross-tolerance (Kurts et al., 1997).
Conferring cytotoxic effector functions to CTLs by cross-
priming requires more than mere antigen cross-presentation. This
realization caused Cohn and Bretscher in 1970 to formulate their
two-signal hypothesis (Bretscher and Cohn, 1970), in which the
ﬁrst signal deﬁnes the speciﬁcity of the T cell response, and the
presence of the second signal caused this response to be immuno-
genic. B7 costimulatory molecules were found to be required for
immunity, and were proposed to be the molecular equivalent of
the enigmatic signal 2 (Allison, 1994). Later it became clear that
B7 molecules are important, but neither essential nor sufﬁcient for
all immune responses. Furthermore, a third signal was postulated
that governs the functional differentiation of the T cell to be acti-
vated (Curtsinger et al., 1999). The molecular correlates of these
three signals are:
(i) peptide antigen presented on MHC class I molecules,
(ii) costimulatory molecules of the immunoglobulin superfamily
(particularly B7, i.e., CD80 and CD86, which bind to CD28 on
T cells) and the tumor necrosis factor (TNF) superfamily (such
as the ligand/receptor pairs CD40L/CD40, 4-1BBL/4-1BB,
CD27/CD70, CD30L/CD30, and HVEM/LIGHT),
(iii) cytokines that stimulate CD8+ T cell expansion and differen-
tiation [IL-12, type I interferon (IFN), IL-2].
Originally, CD8α+ DCs in lymphoid tissue had been described
as the main cell type capable of cross-presentation (Den Haan
et al., 2000).However,CD103+ DCs inperipheral tissues have been
identiﬁed to share this specialization (Del Rio et al., 2007; Bedoui
et al., 2009). Cross-presenting DCs express endocytosis receptors,
including DC-SIGN, CD205, CD206, CD36, or Clec9A (DNGR-1;
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Dudziak et al., 2007; Burgdorf and Kurts, 2008; Caminschi et al.,
2008; Sancho et al., 2009), which enable them to direct exogenous
antigens toward special endosomes where cross-presentation is
believed to occur (Burgdorf et al., 2008).
Until recently, the human correlates of murine CD8α+ DCs
were unknown, as human DCs do not express CD8. In 2010, sev-
eral groups identiﬁed the human CD141+ (=BDCA3) DCs as a
CD8α+-like DC subset (Bachem et al., 2010; Crozat et al., 2010;
Jongbloed et al., 2010; Poulin et al., 2010). These cells share expres-
sion of Clec9A, XCR1, and Necl2, as well as developmental depen-
dence on Batf3, IRF8, and Id2 with their murine equivalents. In
addition, these cells express TLR3, suggesting that similar to what
has been reported for mice, cross-priming by human DCs might
be enhanced by endosomal recognition of double-stranded RNA
(Schulz et al., 2005). Among the functions in common between
human and mouse CD8α+-like DCs are IL-12 production, IFN-λ
expression, and cross-presentation of antigens derived from dead
cell uptake (Jongbloed et al., 2010; Lauterbach et al., 2010; Poulin
et al., 2010).
THE REQUIREMENT FOR A “LICENSE”
It is essential that CD8+ T cell activation be tightly regulated in
order to minimize destruction of uninfected or non-malignant
host tissue. Therefore, the initiation of T cell responses is con-
trolled by a series of checkpoints that allow APCs to selectively
deliver all three signals for CTL activation. A DC that has been
properly activated for this purpose is referred to as a DC“licensed”
for cross-priming (Belz et al., 2004).
One such requirement for efﬁcient cross-priming is the stimu-
lation through innate pattern recognition receptors (PRR) that
recognize pathogen-associated molecular patterns (PAMPs) on
foreign invaders (Maurer et al., 2002). The PRR-induced mat-
uration of DCs and their subsequent migration to secondary
lymphoid organs (SLOs) conﬁrm the “relevance” of the cross-
presented antigen and its “eligibility” to mount an immunogenic
response.
The phenotypic changes induced by PRR signaling in DCs
have been extensively studied. For instance, the activation of TLRs
upregulates costimulatory molecules on DCs and thus increases
signal 2 for efﬁcient cross-priming (Schulz et al., 2005). A recent
study indicated that antigen cross-presentation occurred despite
the lack of a PRR signal, but failed to result in T cell cross-priming
(Keller et al., 2010). Thus, innate stimuli were suggested to enhance
cross-priming without regulating antigen presentation, consis-
tent with the classical two-signal hypothesis (Bretscher and Cohn,
1970). However, a previous study has reported enhanced peptide-
loading on MHC class I molecules after TLR triggering, facilitated
by intracellular relocation of the peptide-loading complex toward
antigen-containing endosomes (Burgdorf et al., 2008).
In addition to TLRs, other PRRs have been implicated in the
regulation of cross-priming efﬁciency. For instance, C-type lectin
receptors have been found to induce DC maturation and upregu-
lation of costimulatory molecules (Rogers et al., 2005). Moreover,
intracellular PRRs such as RIG-I have also been suggested to
enhance CTL responses (Loo and Gale, 2011). Their role in the
regulation of cross-priming, however, remains to be clariﬁed. Fur-
thermore, the cytokine GM-CSF has been shown to preferentially
stimulate cross-presenting DCs (Campbell et al., 2011; Zhan et al.,
2011). The source of such GM-CSF can be cross-primed CTL
themselves (Min et al., 2010).
At present, it is unclear how the PRR signal reaches the DC
that takes up extracellular antigen for cross-presentation (Iwasaki
and Medzhitov, 2010). Nonetheless, it is plausible that, similar
to the antigen, the PRR ligand might be taken up by endocyto-
sis, which makes endosomal TLRs likely PRR candidates for DC
activation for cross-priming. Indeed, the enhancement of cross-
priming is especially effective after TLR3 and TLR9 stimulation
(Maurer et al., 2002; Schulz et al., 2005).
Dendritic cells may acquire antigen also by transfer of pep-
tides (Neijssen et al., 2005), or as preformed MHC-peptide com-
plexes, the latter of which has been termed cross-dressing (Dolan
et al., 2006). Recently, a role for cross-dressing has been described
in memory CTL restimulation, where infected APCs transferred
peptide-MHCcomplexes to the surface of uninfectedDCs (Wakim
and Bevan, 2011), thereby providing them with signal 1 without
the need for further antigen processing. Whether the recipient
DCs need an additional license to activate T cells remains unclear.
However, this need should not be critical in the reactivation of
memory T cells, because these have already undergone a rigorous
activation control during their initial priming.
CLASSICAL LICENSING VIA CD4+ T HELPER CELLS
Apart from signals delivered via innate immune receptors, efﬁ-
cient cross-priming requires the interaction of DCs with antigen-
speciﬁc lymphocytes. Bennett et al. (1998) described that the
induction of cytotoxic T cell responses depends on the previous
activation of a DC by a CD4+ T helper (Th) cell (Bennett et al.,
1998). This concept was termed “cognate licensing,” indicating
that the DC presents the same antigen on MHC class II to the
CD4+ Th cell and on MHC class I to the CD8+ T cell. By func-
tioning as a “second opinion”prior to the elicitation of an efﬁcient
CTL response, the need for this additional interaction reduces
the risk of inappropriate responses against innocuous antigens or
self-peptides. CTLs that did not receive T cell help during prim-
ing (called “helpless” CTLs) show altered effector functions and
lack the capacity to maintain a sustained or memory CD8+ T cell
response (Qiu and Cui, 2007).
It has been shown that the upregulation of costimulatory
molecules on DCs is insufﬁcient for breaking cross-tolerance
to autoantigens. In contrast, Th cells speciﬁc for self-antigens
did provide signals to elicit an immunogenic T cells response
(Hamilton-Williams et al., 2005). Although autoreactive T cells
are present in the periphery despite negative selection in the thy-
mus, an encounter of the antigen-presenting DC with a CD4+
Th cell and a CTL speciﬁc for the same self-antigen seems
very unlikely. Thus, the need for antigen-speciﬁc Th cells to
license DCs for cross-priming serves as an additional check-
point that contributes to the maintenance of peripheral tolerance
to self.
The mechanism of T cell help for cross-priming includes a
plethora of interactions between cell membrane-bound mole-
cules (Figure 1). The signal that has been repeatedly reported
to be essential for this process derives from the interaction of
CD40 on the DC with its ligand CD40L (CD154) on Th cells
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FIGURE 1 | Classical DC licensing for cross-priming is mediated byTh
cells and enhanced byTLR ligands. DCs interact with Th cells via antigen
that is presented on MHC class II and recognized by theTCR and via
CD40–CD40L interactions. The signals downstream of CD40 andTLRs lead
to the upregulation of MHC class I and CD80/86, thus allowing the DC to
interact with CTL.
(Bennett et al., 1998). One main mechanism of CD40–CD40L
interaction is the induction of IL-12 production as a signal 3 for
CTL activation (Schulz et al., 2000). CD40 upregulation requires
innate signals through TLRs (Gallucci et al., 1999) or C-type
lectins (Geijtenbeek et al., 2004). In turn, the consecutive signal
provided by Th cells through CD40L is important for further acti-
vation of the DC, including the upregulation of costimulatory
molecules and the secretion of cytokines necessary for CTL acti-
vation (Grewal and Flavell, 1998). Of note, one study reported that
CD40 stimulation could replace Th cell-mediated licensing in vitro
(Ridge et al., 1998), raising the question of whether CD40 ligation
alone is sufﬁcient as a ﬁnal step in DC activation. A contrasting
view supports the opinion that different receptor–ligand combi-
nations might have overlapping functions and can all contribute
to reaching a threshold level of DC activation that renders the DC
capable of cross-priming (Castellino and Germain, 2006), assum-
ing that a certain number of signals must exist that conﬁrm the
“immunogenic relevance” of the cross-presented antigen before a
CTL response is elicited.
ALTERNATIVE LICENSING VIA NKT CELLS
Recently, natural killer T (NKT) cells were identiﬁed as a second
cell type capable of cognate DC licensing (Semmling et al.,
2010). NKT cells expressing invariant TCRs recognize glycolipid
antigens presented by DCs on the MHC-like molecule CD1d.
The synthetic NKT cell ligand α-galactosylceramide (αGalCer)
has been widely used as a model antigen in many studies,
however pathogen-associated antigens and the mode of NKT
cell activation in different disease models have to be further
clariﬁed. A recent study showed that house dust extracts
contain NKT cell-activating antigens which function as adjuvants
in NKT cell-dependent immunization models, suggesting a role
for NKT cells in the response to environmental antigens (Wingen-
der et al., 2011). Upon recognition of their antigen, NKT cells can
induce the upregulation of costimulatory molecules on DCs (Fujii
et al., 2003). This interaction also activates NKT cells to upreg-
ulate CD40L and to rapidly produce cytokines. CD40 signaling
plays a crucial role in the activation process, and CD40-deﬁcient
mice are unable to develop enhanced CD8+ T cell responses
despite the upregulation of DC maturation markers (Fujii et al.,
2004).
TheNKTcell-DC interactionwas recently deﬁned as a bonaﬁde
cognate licensing process, since the very same DC had to present
the glycolipid antigen to NKT cells and the peptide antigen to
CTLs in order to prime an efﬁcient cytotoxic response (Figure 2).
Furthermore, this “alternative” DC licensing occurred completely
independent from “classical” Th cell-mediated licensing, since it
was unimpaired in the absence of CD4+ Th cells (Semmling et al.,
2010). Although the role of alternative DC licensing in the host
defense against infections and in immune-mediated diseases still
remains to be demonstrated, it appears that at least two analo-
gous systems have evolved to synergistically license DCs for CTL
cross-priming after presentation of peptide and lipid antigens,
respectively.
CHEMOKINES AS REGULATORS OF CROSS-PRIMING
The concept of DC licensing implies that at least three rare
immune cells – a DC capable of antigen cross-presentation, an
antigen-speciﬁc CTL, and an antigen-speciﬁc Th or NKT cell –
have to physically interact. Chemokines and their receptors are
potent agents regulating suchmulti-cellular interactions. The best-
described example are CCR7 and its ligands CCL19 and CCL21,
which coordinate attraction of both antigen-presenting DCs and
naïve T cells into the T cell zone of SLOs. By recruiting both cell
types to the same compartment inside of SLOs, CCR7 increases
the likeliness of an encounter between a naïve T cell and its cognate
antigen on a DC (Forster et al., 2008). Moreover, these chemokines
increase the basal motility of lymphocytes in SLOs and thus
provide an additional means to facilitate DC/T cell encounters
(Worbs et al., 2007). However, the regulation of cognateDC licens-
ing necessitates an even more precise positioning involving more
than two cells. To date, several chemokine/chemokine receptor
pairs have been shown to facilitate this task.
CCR5 AND ITS LIGANDS
Castellino et al. (2006) ﬁrst described the involvement of a
chemokine/chemokine receptor pair in the recruitment of CD8
T+ cells for cross-priming. They showed that CTL were prefer-
entially attracted toward mature DCs that had previously been
licensed by a Th cell. This attraction depended on CCR5 expres-
sion on CTLs and happened in an antigen-independent way.
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FIGURE 2 | Alternative DC licensing for cross-priming is mediated by
NKT cells recognizing glycolipid antigens. DCs interact with NKT cells
via glycolipid antigen that is presented on CD1d and recognized by an
invariant TCR. Moreover, CD40–CD40L interactions lead to an upregulation
of costimulatory molecules for CTL cross-priming.
CCR5 is upregulated on naïve CTLs in the inﬂammatory milieu
of a “challenged” SLO. The CCR5 ligands CCL3 and CCL4 are
produced by Th cells and DCs after their antigen-speciﬁc interac-
tion, thereby creating a chemokine micromilieu which recruits
naïve CCR5-expressing CTLs. Subsequent studies showed that
these chemokines surround a network of ﬁbroblastic reticular
cells (FRCs) which serve as roadways for naïve CTLs (Germain
et al., 2008). Together, the chemokine trace and the FRC network
facilitate efﬁcient CD8+ T cell migration toward DCs licensed for
cross-priming.
A subsequent report by Hugues et al. (2007) conﬁrmed the
involvement of CCR5 in T cell help and extended it by demon-
strating that CTLs themselves can contribute to CCR5-dependend
attraction of further naïve CTLs toward DCs that evidently have
cross-primed successfully.
THE CCR4 – CCL17 AXIS
The production of CCR5 ligands does not play a role in
NKT cell-mediated DC licensing. Instead, alternatively licensed
splenic CD8α+ DCs produced CCL17 (Semmling et al., 2010).
After systemic administration of αGalCer, these DCs speciﬁ-
cally attracted naïve CTLs expressing the CCL17 receptor CCR4,
thereby greatly enhancing the efﬁciency of the cross-priming.
When DCs could not produce CCL17, or if CTLs did not express
CCR4, the enhancement of cross-priming byNKT cells wasmostly
abrogated. Furthermore, the very same DC that produced
CCL17 also cross-presented antigen to CTLs, demonstrating
that chemokine production is a speciﬁc feature of alternatively
licensed DC.
The identiﬁcation of distinct chemokine/chemokine receptor
pairs for classical and alternative licensing support their inde-
pendent roles in the initiation and enhancement of CTL cross-
priming. In addition, these ﬁndings suggest that the principle of
chemokine-mediatedCTL recruitment toward antigen-presenting
DCs is a common component of “help” delivered to DCs through
cognate licensing.
CXCR3 AND ITS LIGANDS
Until recently, it was thought that once primed in SLOs by a
licensed DC, CTLs can freely enter inﬂamed tissues and sites
of infection in the periphery, depending of the inﬂammatory
chemokine receptors they express. Interestingly, however, a study
by Nakanishi et al. (2009) suggested that at least for some tissues, T
cell help by CD4+ Th cells in the periphery is required for efﬁcient
CTL recruitment because when transferred to a mouse lacking
CD4+ Th cells, CTL accumulation at the site of viral infection
was severely impaired. Here again, chemokines were found to be
the central mediators of CTL recruitment. CTLs had to express
CXCR3, the receptor for CXCL9 and CXCL10, to gain access to
virally infected vaginal tissue. Chemokine-mediated CTL recruit-
ment, in turn, was dependent on IFN-γ production by Th cells.
Since Th cell activation and IFN-γ production in the periphery
is known to be mediated by inﬁltrating DCs (Wakim et al., 2008;
Mclachlan et al., 2009), it is possible that, similar to CTL attraction
in SLOs, DCs are the central hubs that initiate CTL recruitment to
sites of infection.
XCR1 AND XCL1
A further chemokine/chemokine receptor pair critically involved
in cross-priming is XCR1–XCL1 (Dorner et al., 2009). However, in
contrast to the CCR4 and CCR5 systems, this interaction does not
appear to serve the attraction of naïve CTLs toward cross-priming
DCs. Instead, in this interaction the cross-presenting DC expresses
the receptor, not the ligand, suggesting that the information ﬂow
occurs in the opposite direction. Notably, XCR1 is exclusively
expressed on cross-presenting CD8+ DCs in the spleen and lymph
nodes (LNs), indicating a dedicated role in cross-priming. Its lig-
andwas secretedmainly by cross-primedCTLs 12–48 h after initial
antigen contact. How exactly XCR1 and XCL1 interact to enhance
cross-priming is unclear. Under immunogenic conditions, XCL1-
deﬁciency in T cells results in a lower CTL number and impaired
in vivo cytotoxicity 12 days after the initial antigen encounter.
Without an immunogenic stimulus, the XCL1–XCR1 axis does
not seem to play a role, as XCL1-deﬁcient CTLs behaved similar to
the wildtype control, suggesting that XCR1 might not be critical
for cross-tolerance.
The peak of XCL1-expression occurred when the interaction
between CTL and DC was most stable, suggesting that XCL1 sta-
bilizes the contact between CTL and DC (Dorner et al., 2009).
It needs however to be formerly demonstrated whether XCL1-
deﬁciency indeed shortens CTL–DC interactions and/or reduces
cross-priming. Another possible mechanism is that XCL1 attracts
additional CD8+ DCs to the site where the initial cross-presenting
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DC acquired antigen. These additional DCs might then take up
and process the antigen as well, thereby increasing the overall
antigen-presenting capacity.
The importance of the XCR1–XCL1 axis is underlined by its
conservation between species. Like murine CD8+ DCs, human
CD141+ XCR1+ DCs are able to cross-present antigen to CD8+
T cells and migrate in response to a XCL1 gradient (Bachem et al.,
2010). Together with BDCA3, a recently identiﬁed marker for the
human equivalent of CD8+ murine DCs (Poulin et al., 2010),
XCR1 has been proposed as a marker to identify cross-presenting
DCs.
THE SIGNAL 0 HYPOTHESIS
From these studies, chemokine-mediated attraction of naïve CTLs
has emerged as a novel mechanism that facilitates cross-priming,
extending the list of signal 1 (antigen on MHC class I), 2 (cos-
timulatory molecules), and 3 (cytokines) to a fourth signal. Since
chemokines mediate CTL recruitment and consequently act before
the other signals come into play, it has been proposed to refer to
the chemokine trace as “signal 0” (Bousso and Albert, 2010).
Thus, chemokines do not only locate DCs and CTLs to the
same compartment inside of SLOs, they also actively recruit CTLs
to sites of DC licensing where mature, antigen-presenting DCs
can readily prime naïve CTLs. After T cell entry into SLOs, CCR7
ligands enhance motility, and positioning in the T cell zone to
restrict the area of potential DC/T cell encounters. Subsequently,
ligands for CCR5 and CCR4 bias the migration of CTL toward
Th cell- and NKT cell-licensed DCs, respectively. This directed
migration highly enhances the efﬁciency of CTL responses, due to
a more rapid activation and the attraction of higher numbers of
CTLs.
Remarkably, when classical and alternative DC licensing acted
simultaneously in a non-infectious immunization model, both
chemokine systems synergistically enhanced CTL recruitment
(Figure 3). Thus, CTL priming was most efﬁcient when DCs
received bothTh cell- andNKTcell-mediated licensing (Semmling
et al., 2010). Although it is unclear whether similar synergis-
tic effects also exist at the level of signals 1–3, the concept that
DC licensing might not be an “on”-or-“off”-phenomenon, but
instead exists at several intermediate levels of licensing capacity,
has important implications for vaccination strategies. The strength
of cross-priming capability might hence be determined by the
integrationof all licensing signals that a particularDChas received.
OPEN QUESTIONS REGARDING THE SIGNAL 0 HYPOTHESIS
There are many unanswered questions on the regulation of sig-
nal 0 chemokines in CTL cross-priming. First, it is currently
unknown which molecular signals induce chemokine expression
FIGURE 3 | Synergy of classical and alternative licensing. It is known
that classical licensing leads to CTL attraction via the secretion of
ligands for CCR5. In contrast, CTL recruitment toward alternatively
licensed DCs acts via ligands for CCR4. By taking advantage of both
systems, DCs are rendered even more attractive to CTLs, which leads to an
increased exploitation of the few antigen-speciﬁc CTLs from the precursor
pool. How CCR4 and CCR5 are upregulated on naïve CTL is currently
unknown.
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in DCs. Both soluble factors and membrane-bound molecules are
involved in the interactions between DCs and helper cells, but
their precise role in signal 0 induction remains to be addressed.
Second, the signals which render naïve CTL response to different
chemokines remain elusive. It is well known that primed effec-
tor CTL upregulate the chemokine receptors CCR2, CCR5, and
CXCR3, which allow them to enter infected tissues expressing
several chemokines, including CCL2, CCL3, CCL4, CCL5, and
CXCL10 (Bromley et al., 2008). However, since neither CCR5 nor
CCR4 have been associated with circulating naïve CTL, it is con-
ceivable that these receptors are upregulated around the time of
entry into SLOs, depending on the inﬂammatory milieu. Then
again, however, it is unclear which cells produce the factors that
lead to the upregulation of chemokine receptors on CTL prior
to antigen recognition. A recent study indicated that DC/Th cell
interactions strongly enhance naïve CD8+ T cell input into LNs
through vascular remodeling of the LN feed arteriole (Kumamoto
et al., 2011). This effect required DC licensing though CD40 sig-
naling. This ﬁnding suggests that signals derived from DC/Th
cell interactions may act on endothelial cells of SLOs, thereby
facilitating CTL entry and chemokine responsiveness.
Both CCR5 and CCR4 were found to be expressed only
by subsets of naïve CTL (Castellino et al., 2006; Semmling
et al., 2010). It is not yet clear whether this was simply due
to limiting amounts or availability of the elusive factor(s) that
lead to the upregulation of chemokine receptors on naïve
CTL, but it is equally possible that several subsets of naïve
CTL precursors exist which are capable of upregulating distinct
chemokine receptors – potentially in response to early media-
tors that are released into the circulation and inform circulat-
ing CTL about the pathogenic proﬁle of a local infection. It
will be interesting to see whether further chemokine/chemokine
receptor pairs are involved in the guidance of naïve CTL
through their search for cognate antigen presented by an acti-
vated DC.
IMPLICATIONS OF THE SIGNAL 0 HYPOTHESIS ON THE
SPATIAL AND TEMPORAL ORCHESTRATION OF DC
LICENSING AND CROSS-PRIMING
The concept of chemokine-mediated CD8+ T cell attraction
toward DCs for cross-priming opens a new view on T cell prim-
ing in SLOs. First, early imaging studies suggested that T cell
migration in SLOs follows the pattern of random walk kinetics
at a speed of about 10μm/min (Miller et al., 2002). This pic-
ture was later reﬁned by the discovery that T cells migrate along
deﬁned roadways consisting of a sophisticated FRC network and
that also DCs are associated with this network (Bajenoff et al.,
2006). Chemokines nowappear to function as the road signswhich
lead naïve CTL in search for cognate peptide through the maze
of FRCs toward activated DCs (Germain et al., 2008). Whether
chemokines produced by DCs and helper lymphocytes are also
physically attached to the FRC network is not entirely clear, but
one can envision a scenario in which chemokines decorate the
FRC network only in close proximity to a cross-priming“hot spot”
consisting of a licensed DC and one or more helping lymphocytes.
Once a naïve CTL reaches the chemokine trace on its random
walk along the FRCs, its path may now deviate from the random
movement, and the T cell is preferentially recruited to the site of
antigen presentation.
Taken together, the involvement of chemokines in the regu-
lation of cross-priming supports the idea that CTL movement
in SLOs might not be random, but rather directed toward DCs
that are cross-presenting antigen. Consequently, DCs that are pre-
senting multiple relevant microbial antigens will receive multiple
licensing signals, and might potentially co-produce several sets
of chemokines. Guided by signal 0, naïve CTLs hence migrate
preferentially toward areas where the likelihood of ﬁnding the
remaining three signals for full activation and expansion is the
highest.
Second, the notion that three cell types have to engage for effec-
tive CTL cross-priming bears the question how such an interaction
might be spatially orchestrated. In the early 1980s, investigators
ﬁrst noticed the requirement for T cell help for the generation of
an efﬁcient CTL response (Keene and Forman, 1982). Considering
the low frequency of T lymphocytes speciﬁc for antigens from a
single infectious microorganism, they concluded that a mecha-
nism was needed to bring these cells together both temporally and
spatially. The most convincing idea was that this platform is pro-
vided by the DC, because this cell has to engage in physical contact
with both lymphocytes. This notion was supported by the ﬁnding
that indeed the same DC has to present antigen on MHC class II
molecules to Th cells (or on CD1d to NKT cells, respectively) and
on MHC class I molecules to CTLs (Ridge et al., 1998; Semmling
et al., 2010). However, the temporal detail of this interaction, i.e.,
the question whether both lymphocytes have to engage the DC at
the same time, has remained unclear.
The ﬁrst model suggested simultaneous interaction of the DC
with both helper cell and CTL (“three cell cluster” model) and
was consistent with the hypothesis that optimal cross-priming
requires a speciﬁc micromilieu of paracrine factors, such as IL-
2, which are produced by APC-bound Th cells or NKT cells. The
opposing model is based on the conception that an encounter of
three rare immune cells (with the precursor frequency of naïve T
cells speciﬁc for a particular antigen being as low as 1:1,000,000)
is highly improbable. This gave rise to the idea that DCs become
fully licensed by CD4+ Th cells through CD40 and its ligand, and
that the licensing process is sufﬁcient to confer to the DC a cell-
intrinsic cross-priming ability without the need for further help
(“temporal bridge”model). Thus, two serial cell encounters would
sufﬁce because DCs retain the information that they have received
through cognate licensing (Smith et al., 2004). It was deduced from
these results that in vivo, the helper cellmightmove randomly from
DC to DC, scanning for cognate antigen and leaving behind each
“qualiﬁed” DC in a licensed state. Thereby, the capacity of T cell
help is ampliﬁed and produces many licensed DCs from a single
Th cell.
Although no study has directly addressed whether CTLs are
recruited to DCs while the helper lymphocyte is still engaged,
the model that chemokines actively recruit naïve CTLs for cross-
priming sheds new light on the discussion about which model
best describes the cellular interactions involved in this process.
If DCs that are still in contact with the helper lymphocyte (or
even several helper lymphocytes) were more effective chemokine
producers, then a tripartite encounter might be possible, although
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the low precursor frequency argues against this. Investigating the
kinetics of chemokine expression by licensed DCs, as well as the
role of helper lymphocytes for sustained chemokine secretion,will
be critical to further elucidate the orchestration of cellular contacts
involved in CTL cross-priming.
Third, it is known that chemokines inﬂuence CD8+ T cell
priming not only by guiding CTLs to the site of antigen presenta-
tion, but also by modulating the interaction between T cells and
DCs. Friedman et al. (2006) demonstrated that surface-bound
CCL21 prolonged cell contacts during which T cells can scan the
DC surface. This long-lasting contact was necessary to ensure
the sustained signaling that maintains gene transcription and
promotes T cell-cycle progression. The mechanistic events under-
lying the chemokine-dependent increase in contact duration have
been partially characterized. It was suggested that chemokine con-
tacts transiently tether CTLs to chemokine-presenting DCs in
an LFA-1 dependent fashion (Friedman et al., 2006). It is well
established that chemokine receptor activation can increase the
afﬁnity of LFA1 for ICAM1 (Campbell et al., 1998; Iezzi et al.,
1998), which would augment the stability of cell–cell contacts.
Besides integrin-mediated adhesiveness, Friedman et al. (2006)
observed that CTLs acquired a polarized morphology and the
TCR localized toward the contact site, whereby the hyperpolar-
ized T cell gained enhanced sensitivity to antigen at the lead-
ing edge. This might be a mechanism that has a costimulatory
effect on the induction of CTL responses and may also play a
role in CCR5- and CCR4-mediated contact duration. This study
did not ﬁnd any inﬂuence of CCL3 and CCL17 on tethering
of CTL, but this could be due to the fact that untreated CTL
were used which express neither CCR5 nor CCR4. An addi-
tional mechanism that could increase contact duration is the
recruitment of certain chemokine receptors to the immunolog-
ical synapse (IS), a supramolecular structure that forms at the site
of membrane contact between DCs and T cells. CCR4 and CCR5
belong to the so-called subordinate receptors that are recruited
to the IS and subsequently become unresponsive to chemokine
gradients (Bromley et al., 2000; Molon et al., 2005). Through this
mechanism, more stable contacts between DC and CTL might
be formed, thus permitting more extensive scanning of the DC
surface.
OUTLOOK
The recognition of virtually any antigenic structure through a
vast TCR repertoire is one of the most important features of
the adaptive immune system. However, this advantage comes at a
cost, namely the challenge to quickly recruit rare antigen-speciﬁc
precursors for priming and expansion. Chemokine-mediated
attraction toward antigen-presenting DCs, albeit independent of
antigen-speciﬁcity,might play an important role in facilitating this
recruitment and can be exploited for the generation of effective
vaccines.
The discovery of chemokine-mediated recruitment of naïve
CTLs toward classically or alternatively licensed DCs has uncov-
ered an additional functional role of chemokines in the orches-
tration of adaptive immune responses. We are just beginning to
understand the many roles that chemokines play in CTL priming,
and many questions remain. For example, it will be interesting
to see whether and which chemokine signals act as signal 0 in
CD4+ Th cell activation, and whether microbes have developed
ways to evade the signal 0 pathway. Deﬁning the signals that cause
chemokine production by licensed DCs and render naïve CTLs
responsive to these chemokinesmay reveal interesting insights into
the complex regulation of cross-priming and open new avenues
for optimizing vaccine strategies.
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